Tag Archives: Some

Mylan and Pfizer report new issues affecting some EpiPens that can delay treatment

More than a month after Mylan and Pfizer reported to Health Canada that there are new issues affecting some EpiPens, the companies and the FDA notified U.S. healthcare providers of the problem which can delay treatment when the pens are needed. Mylan, Pfizer and the FDA Friday reported that some pens and their authorized generic… Read More »

Study of Cellphone Risks Finds ‘Some Evidence’ of Link to Cancer, at Least in Male Rats

For decades, health experts have struggled to determine whether or not cellphones can cause cancer. On Thursday, a federal agency released the final results of what experts call the world’s largest and most costly experiment to look into the question. The study originated in the Clinton administration, cost $ 30 million and involved some 3,000… Read More »